Harper Cancer Research Institute hosts 7th Annual Cancer Research Day

Author: Brandi Klingerman

On April 9, faculty, students, staff, and the public are invited to attend the Harper Cancer Research Institute’s seventh annual Cancer Research Day. This flagship event highlights cancer research at the University of Notre Dame as well as other local cancer organizations.

“For the past six years, the Harper Cancer Research Institute (HCRI) has been proud to offer this event and invite all those interested to learn about the state of cancer research and how the University of Notre Dame is contributing to the fight,” said M. Sharon Stack, Ann F. Dunne and Elizabeth Riley Director of the HCRI and Kleiderer-Pezold Professor of Chemistry and Biochemistry. “We are grateful to have community organizations like Smoke Free St. Joe County, RiverBend Cancer Services, St. Joseph Health Systems, and others involved throughout the day.”

7

Throughout the event, attendees will have the opportunity to participate in a variety of activities to learn about research happening at the HCRI. In the morning, Notre Dame undergraduate students, graduate students, and postdoctoral scholars, in addition to local high school students, will present their research during a poster session and answer visitor questions about their posters. Also, during this time, cancer survivors will tell their stories about their personal experience with cancer.

In the afternoon, keynote speaker Cynthia Reinhart-King, Cornelius Vanderbilt Professor of Engineering at Vanderbilt University, will present “The Mechanics of Metastatic Cell Migration.” Afterward, multiple awards, including the Dr. Michael Rodrigues Memorial Award, will be presented to researchers with a reception to follow.

All of these events, as well as a career panel, an ovarian cancer survivors meeting, and more will take place throughout the day. 

Investigators in the HCRI are dedicated to conducting innovative and integrative research that confronts the complex challenges of cancer. From common malignancies to rare and recalcitrant cancers, researchers at Notre Dame and Indiana University School of Medicine-South Bend are united in multi-disciplinary teams with a common goal: to increase the survival of all patients diagnosed with cancer.

 To learn more, visit harpercancer.nd.edu.

Originally published by Brandi Klingerman at harpercancer.nd.edu on April 03, 2018.